CA2605226A1 - Composition d'analogues de nucleotides et procede de synthese - Google Patents

Composition d'analogues de nucleotides et procede de synthese Download PDF

Info

Publication number
CA2605226A1
CA2605226A1 CA002605226A CA2605226A CA2605226A1 CA 2605226 A1 CA2605226 A1 CA 2605226A1 CA 002605226 A CA002605226 A CA 002605226A CA 2605226 A CA2605226 A CA 2605226A CA 2605226 A1 CA2605226 A1 CA 2605226A1
Authority
CA
Canada
Prior art keywords
pmpa
composition
diethyl
useful
synthesis method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002605226A
Other languages
English (en)
Other versions
CA2605226C (fr
Inventor
John D. Munger, Jr.
John C. Rohloff
Lisa M. Schultze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Gilead Sciences, Inc.
John D. Munger, Jr.
John C. Rohloff
Lisa M. Schultze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/900,752 external-priority patent/US5935946A/en
Application filed by Gilead Sciences, Inc., John D. Munger, Jr., John C. Rohloff, Lisa M. Schultze filed Critical Gilead Sciences, Inc.
Priority claimed from CA002298059A external-priority patent/CA2298059C/fr
Publication of CA2605226A1 publication Critical patent/CA2605226A1/fr
Application granted granted Critical
Publication of CA2605226C publication Critical patent/CA2605226C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002605226A 1997-07-25 1998-07-23 Composition d'analogues de nucleotides et procede de synthese Expired - Lifetime CA2605226C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US5377797P 1997-07-25 1997-07-25
US08/900,752 1997-07-25
US60/053,777 1997-07-25
US08/900,752(CON) 1997-07-25
US60/053,777(CON) 1997-07-25
US08/900,752 US5935946A (en) 1997-07-25 1997-07-25 Nucleotide analog composition and synthesis method
CA002298059A CA2298059C (fr) 1997-07-25 1998-07-23 Composition d'analogues de nucleotides et procede de synthese

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002298059A Division CA2298059C (fr) 1997-07-25 1998-07-23 Composition d'analogues de nucleotides et procede de synthese

Publications (2)

Publication Number Publication Date
CA2605226A1 true CA2605226A1 (fr) 1999-02-04
CA2605226C CA2605226C (fr) 2009-01-13

Family

ID=39092645

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002605226A Expired - Lifetime CA2605226C (fr) 1997-07-25 1998-07-23 Composition d'analogues de nucleotides et procede de synthese

Country Status (1)

Country Link
CA (1) CA2605226C (fr)

Also Published As

Publication number Publication date
CA2605226C (fr) 2009-01-13

Similar Documents

Publication Publication Date Title
CA2298059A1 (fr) Composition d'analogues de nucleotides et procede de synthese
AU635209B2 (en) Oligonucleotide analogs containing sulfur
ES8800157A1 (es) Un procedimiento para preparar derivados de tironina
HU195657B (en) Process for production of carbocyclic pirin nucleorids and medical compounds containing them
MARUYAMA et al. Synthesis and antiviral activities of carbocyclic oxetanocin analogues
Murakami et al. Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2', 3'-dideoxypurine nucleosides
EP0393494A3 (fr) Dérivés d'acide biliaire, procédé pour leur préparation et les compositions pharmaceutiques les contenant
JPH01308267A (ja) 新規なアリステロマイシン／アデノシン誘導体類
US4315920A (en) Adenosine deaminase inhibitors
EP0361831B1 (fr) Mélange antiviral de nucléosides
Wojtkowski et al. . beta.-Thionolactam analogs of cephalosporins and penicillins
CA2605226A1 (fr) Composition d'analogues de nucleotides et procede de synthese
GB2084152A (en) Antiviral agents their preparation and use
EP0287215B1 (fr) Nucléosides thérapeutiques
ATE34176T1 (de) 2'-chloropentostatin, eine diese verbindung enthaltende pharmazeutische zusammensetzung und ein mikroorganismus zur herstellung dieser verbindung.
AU8282587A (en) 6-7-dihydro-(1,2,4)triazolo(1,5-a)(1,3,5)triazin-2-sulphon- amides, processes for their preparation and their use as herbicides and plant growth regulators
Mikotajczyk et al. Nucleophilic substitution at sulfinyl sulfur. Factors affecting the inversion to retention ratio in acid-catalyzed alcoholysis of chiral n, n-di isopropyl p-toluenesulfinamide
Hodge et al. Use of isotopically chiral [4′‐13C] famciclovir and 13C NMR to identify the chiral monoacetylated intermediates in the conversion of famciclovir to penciclovir by human intestinal wall extract
DE69029547D1 (de) Purinverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate und Zwischenverbindungen
CZ18093A3 (en) Novel derivatives of phospholipid nucleosides, process of their preparation as well as their use as antiviral medicaments
JPS6434996A (en) Fluorocyclopentane derivative and production thereof

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180723